Clinical Trial Update: Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update comparing consolidation regimens of IDA with intermediate-dose cytarabine versus intermediate-dose cytarabine alone in elderly AML patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• IDA with intermediate-dose cytarabine (idarubicin? (not specified))
• intermediate-dose cytarabine (cytarabine)

Snippet

Sponsor: Fujian Medical University | Conditions: AML in Remission | Phase 2, Phase 3 | Status: UNKNOWN